# Current Shared Status

Updated: 2026-10-16, Asia/Calcutta (`agent/argon-continue`).

## Implemented & Verified

- **Full Test Suite & Originals Integrity**:
  - `python verify_sources.py`: Verified all 6 original template SHA-256 hashes byte-for-byte (`Marksans Keshav.xlsx`, `ERR-4.pptx`, three `GMCC 2023` decks, and `Healthcare and Pharma Industry Primer Final.pptx`).
  - `python -m unittest discover -v`: 56/56 unit tests pass cleanly (33 in `test_modelmaker.py`, 11 in `test_pptmaker.py`, 5 in `test_build_package.py`, 7 in `test_reportmaker.py`).

- **Repeatable Package Build Orchestrator (`build_package.py`)**:
  - Implemented end-to-end repeatable build entry point with formal request schema (`package-request.schema.json`) and shipped Marksans configuration (`examples/marksans-package.json`).
  - Strict destination directory safety: refuses to clobber existing non-empty output directories without explicit `--force`.
  - Pinned SHA-256 hash enforcement: validates source workbook (`5a1f9af7...`) and presentation template (`9d41ec99...`) prior to execution.
  - Generates comprehensive `package.manifest.json` recording execution timestamp, source hashes, recalculated workbook validation status, financial reconciliation table, and 13 generated artifact hashes.
  - Native Windows COM integration: exports 1080x1440 PNG slide previews via PowerPoint COM and landscape `FitToPagesWide = 1` multi-column schedule PDFs via Excel COM.

- **Financial Reconciliation & Scope Honesty**:
  - **Capital Structure Weights Reconciled**: Discrepancy between Current Capital Structure ($₹343$ Cr debt = $2.39\%$, $₹14,003$ Cr equity = $97.61\%$) and Target Capital Structure (Debt weight $2.24\%$, Equity weight $97.76\%$ from `WACC-DCF!E30:E31`) resolved and explicitly labeled. Damodaran DCF methodology target-weighted WACC ($12.11\%$) verified with zero rounding ambiguity.
  - **Debt Definition Unified**: Unified to `Total Debt / Borrowings` from `Data Sheet!K59` ($₹343.38$ Cr), retiring legacy Sun Pharma "Long term Debt" labeling.
  - **CAPM Cost of Equity Reconciled**: $R_f = 7.30\%$, $R_m = 16.37\%$ ($R_m - R_f = 9.07\%$), $\beta = 0.547$, yielding $K_e = 7.30\% + 0.547 \times 9.07\% = 12.26\%$.
  - **Cost of Debt Reconciled**: Pre-tax $K_d = 8.00\%$, Tax Rate $= 30.00\%$, Post-tax $K_d = 5.60\%$.
  - **Slide 16 Ratio Table & Charts Reconciled**: Fully mapped Table 0 across FY18–FY25 (64 data cells) with verified Screener.in ratios. Native Current Ratio chart ($3.18 \to 4.95$) and Quick Ratio chart ($1.64 \to 3.07$) tie out 100% with Table 0 rows 1 and 2.
  - **Chart Titles & Semantics Audited**: Slide 2 chart retitled from misleading "Revenue by Segment" to "Historical Revenue (₹ Crore)" ($₹1,376$ Cr to $₹2,623$ Cr) and "FY25 Financial Snapshot (₹ Crore)". Slide 1 Chart 1 updated to authentic Marksans geographic Revenue Mix (UK & Europe 43.1%, US 41.7%, Australia & NZ 9.8%, RoW 5.4%).
  - **Scope Description**: Accurately defined as a **"5-Slide Marksans Pharma Financial Overview"** (company profile, executive summary, 8-year cash flow, ratio analysis, and DCF WACC schedule), avoiding unevidenced equity research price targets or recommendations.

- **Marksans 17-Sheet Equity Research Model Pack & Recalculation Evidence**:
  - Comprehensive model pack proposal (`proposals/marksans.model-pack.proposal.json`) with 93 editable inputs.
  - Candidate workbook generated and recalculated using native Microsoft Excel COM 16.0: `candidates/Marksans-Recalculated.xlsx` (SHA-256: `9c1fa6e39d88d3bb597de8e4cf6208170471751cb87580aa7c8b6255dd6054e8`).
  - Validation report (`candidates/Marksans-Validation-Report.json`): 19/19 pack checks passed, 29/29 independent financial identities passed, 0 formula errors, 0 uncalculated caches.

- **Template-Preserving PowerPoint Inspector & Composer (`pptmaker.py`)**:
  - Full DrawingML and Chart namespace serialization: registers complete namespaces (`c`, `a`, `r`, `mc`, `c14`, `c15`, `c16`, `c16r2`, `c16r3`, `p14`, `p15`).
  - Native `<c:title>` updating with run property preservation (`_set_paragraph_text_preserving_rpr`).
  - 139 verified slots in `proposals/err4.deck-pack.proposal.json` and `proposals/err4.inputs.proposal.json`.
  - Unverified corporate logos cleanly suppressed (`suppress_shape`).

## Current Readiness State

Both model and deck outputs maintain `ready: false` with explicit pending gates:
- Excel Model: `ready: false`, `pending_gates: ["human_pack_approval"]`.
- PowerPoint Deck: `ready: false`, `pending_gates: ["human_pack_approval", "render_review"]`.

## Next Steps

1. Independent human review and approval of `proposals/marksans.model-pack.proposal.json` and `proposals/err4.deck-pack.proposal.json`.
2. Sourcing and verifying authentic vector SVG/PNG asset for `marksans_corporate_logo`.
